The cost of asthma control
Asthma care has advanced significantly. This is attributed to a better understanding of clinical disease phenotypes and overlapping molecular endotypes amenable to therapy. Despite improvements inasthma care, rates of asthma control remain suboptimal. Adult asthma rates in Asia are lower than that in...
| מחבר ראשי: | |
|---|---|
| מחברים אחרים: | |
| פורמט: | Journal Article |
| שפה: | English |
| יצא לאור: |
2017
|
| נושאים: | |
| גישה מקוונת: | https://hdl.handle.net/10356/80789 http://hdl.handle.net/10220/42255 |